Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes

HAO-CHUN CHANGKUAN-YU CHENYIH-LEONG CHANGJIN-YUAN SHIHCHONG-JEN YU2023-01-172023-01-1720230929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/627363Among the histologic types of lung cancer, adenocarcinoma is the most common. Moreover, lung adenocarcinoma with neuroendocrine differentiation (LANED) is a rare histologic character. So far, the clinical significance remains unclear.enAdenocarcinoma; Chemotherapy; Lung cancer; Neuroendocrine differentiation; Overall survivalLung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomesjournal article10.1016/j.jfma.2022.12.011365867852-s2.0-85145710256https://api.elsevier.com/content/abstract/scopus_id/85145710256